Effects of Gestational Diabetes Management on Pregnancy Outcome

Objective: To investigate the effect of pregnancy management on pregnancy outcomes of patients with Gestational Diabetes Mellitus (GDM). Methods: A total of 334 patients with GDM diagnosed in a tertiary hospital in Xinjiang from November 1, 2017 to October 31, 2018 and from November 1, 2020 to October 31, 2021 were collected as subjects. According to the inclusion and exclusion criteria, patients were selected as the control group (141 cases) in 2017 and the management group (193 cases) in 2020. The control group was treated with conventional diagnosis and treatment methods, and the management group was treated with pregnancy health care in strict accordance with the established pregnancy management methods. The influencing factors of GDM were analyzed by single factor and multiple factor logistic regression analysis. Results: Through pregnancy management, the amount of postpartum hemorrhage in the management group was less than that in the control group, and the incidence of premature rupture of membranes was lower than that in the control group (P < 0.05). The neonatal weight of the management group was lower than that of the control group, and the incidence of premature delivery, amniotic fluid pollution, dystocia and neonatal hypoglycemia were all lower than those of the control group (P < 0.05). Logistic regression analysis was used to analyze the influence of pregnancy management strategy on the pregnancy outcome of GDM patients. The results showed that pregnancy management strategy could reduce the probability of postpartum hemorrhage, premature rupture of membranes, premature delivery, macrosomia, perinatal hypoglycemia and cesarean section. Conclusion: The pregnancy management strategies formulated in this study (diet therapy, exercise therapy, insulin therapy, blood glucose monitoring, perinatal monitoring) can significantly reduce the incidence of complications of pregnant women and newborns. The application of pregnancy management in the clinical treatment of GDM patients can effectively help patients improve their pregnancy outcomes and reduce the incidence of adverse pregnancy outcomes of pregnant women and newborns, which is worthy of clinical application and promotion.